Aerpio Therapeutics Announces Successful Completion of Phase 1b/2a Trial in

Aerpio Therapeutics Announces Successful Completion of Phase 1b/2a Trial in

Filed under: drug treatment program in cincinnati ohio

CINCINNATI, OH, USA I November 6, 2013 I Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today announced the successful completion of its Phase 1b/2a study of …
Read more on PipelineReview.com (press release)